Leflunomide Timing of Administration
Leflunomide can be taken at any time of day without regard to meals, though taking it with food may help reduce gastrointestinal side effects if they occur.
Dosing Flexibility
The available evidence does not specify an optimal time of day for leflunomide administration. Unlike some medications with circadian-dependent mechanisms (such as short-acting statins that should be taken in the evening due to nighttime cholesterol synthesis), leflunomide's mechanism of action—inhibiting pyrimidine synthesis and T-cell proliferation—does not have a time-dependent component.
The standard dosing regimen is 20 mg once daily, which can be administered at any time that works best for the patient 1. The FDA label and clinical guidelines consistently describe leflunomide as a once-daily medication without specifying morning versus evening administration 2.
Practical Considerations for Timing
Managing Gastrointestinal Side Effects
- If nausea or diarrhea occurs (common side effects affecting up to 15% of patients), consider taking leflunomide with food or at bedtime 1
- This approach mirrors strategies used with other medications that cause GI upset
- The drug can be taken without regard to meals, so timing flexibility exists 2
Optimizing Adherence
- Choose a consistent time that fits the patient's daily routine
- For patients on multiple medications, coordinate timing to minimize pill burden and improve compliance
- The long half-life of leflunomide's active metabolite (approximately 2 weeks) means that minor variations in daily timing have minimal clinical impact
Loading Dose Considerations
When initiating therapy, the typical loading dose is 100 mg daily for 3 days, followed by 20 mg daily maintenance 1. However:
- Avoiding the loading dose reduces early "nuisance" side effects like nausea and diarrhea 3
- The trade-off is a delayed onset of therapeutic effect
- If using a loading dose and GI symptoms develop, splitting the dose or taking with meals may help
Key Monitoring Points
Regardless of timing chosen:
- Monitor ALT monthly for the first 6 months, then every 6-8 weeks 1
- Monitor CBC with differential on the same schedule
- Most hepatotoxicity occurs within the first 6 months 2
The bottom line: Select a time that maximizes patient adherence—whether morning, evening, or with a specific meal—as consistency matters more than the specific time chosen.